Clinical Trial Update: Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) [Phase 2, Phase 3]

View source ↗

Summary

A pediatric dose-escalation trial for crofelemer powder in oral solution is ongoing for Microvillus Inclusion Disease, with Phase 2 and Phase 3 stages and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvillus Inclusion Disease

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Napo Pharmaceuticals, Inc. | Conditions: Microvillus Inclusion Disease, Congenital Disorders | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING